blinatumomab,dasatinib,ponatinib
otsuka,amgen,takeda,astellas,incyte
['blinatumomab', 'ponatinib', 'ph+ all', 'dasatinib']
extremely impressive results for frontline #blinatumomab and #ponatinib in front line ph(+) all - however i can only imagine the insurance pushback in use outside a clinical trial. #twitterx #ash22 
Inpatient Hematology Oncology Clinical Pharmacy Coordinator, @UMiamiHealth ????| PGY2: @MoffittNews | PGY1: @EinsteinHealth | @TempleUniv | Go Birds ?? my views